Morgan Joseph reiterates a 'Buy' rating on Genzyme (Nasdaq: GENZ), price target $76.

Morgan analyst says, "Genzyme reported an in-line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE